Lisa Delfini

Lisa Delfini

Chief Financial OfficeratTrevi Therapeutics· In proxies 2023–2024

Pay in FY2024Trevi Therapeutics stock +207.5% the same year

Lisa Delfini was paid $1.2M in FY2024 (Dec). Trevi Therapeutics stock rose 207.5% that year.

Pay$100 in the stock at the end of FY22 → $213
Pay is from the Summary Compensation Table of each Trevi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Trevi TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +631%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?